Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
Exercise as a modulator of purinergic signaling and inflammation in cancer-associated sarcopenia: a narrative review.
СтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
de Oliveira Emeline Moraes, Dockhorn Vitor Mariano Gonçalves, de Souza João Victor Garcia, Franscescon Francini, de Resende E Silva Débora Tavares
Аннотация
BACKGROUND: Sarcopenia, characterized by the progressive loss of skeletal muscle mass and strength, is highly prevalent among cancer patients and is strongly associated with poor prognosis. Increasing evidence indicates that overactivation of the purinergic system contributes to a chronic inflammatory state that promotes tumor progression and exacerbates muscle wasting.
PURPOSE: This narrative review examines how physical exercise may modulate purinergic signaling and inflammation, potentially improving the quality of life of cancer patients with sarcopenia.
METHODS: A literature search was conducted in the MEDLINE database via PubMed, including articles published between 2008 and 2025, using descriptors such as "purinergic signaling", "CD39", "CD73", "P2X7 receptor", "adenosine", "sarcopenia", "skeletal muscle metabolism", "cancer", "inflammation", and "extracellular ATP".
RESULTS: Original studies and review articles in English addressing the relationship between purinergic pathways, inflammation, muscle metabolism, and cancer were included.
CONCLUSIONS: Findings suggest that cancer-related sarcopenia is closely linked to systemic inflammation mediated by purinergic pathways, and evidence indicates that exercise may play a pivotal role in mitigating muscle loss and improving patient outcomes.
PURPOSE: This narrative review examines how physical exercise may modulate purinergic signaling and inflammation, potentially improving the quality of life of cancer patients with sarcopenia.
METHODS: A literature search was conducted in the MEDLINE database via PubMed, including articles published between 2008 and 2025, using descriptors such as "purinergic signaling", "CD39", "CD73", "P2X7 receptor", "adenosine", "sarcopenia", "skeletal muscle metabolism", "cancer", "inflammation", and "extracellular ATP".
RESULTS: Original studies and review articles in English addressing the relationship between purinergic pathways, inflammation, muscle metabolism, and cancer were included.
CONCLUSIONS: Findings suggest that cancer-related sarcopenia is closely linked to systemic inflammation mediated by purinergic pathways, and evidence indicates that exercise may play a pivotal role in mitigating muscle loss and improving patient outcomes.